Back to search

Article

A diagnosis model for prostate adenocarcinoma based on hub genes targeted by sulforaphane

2025-12-12

Abstract excerpt

<title>Abstract</title> <p>Prostate adenocarcinoma (PRAD) is the fifth leading cause of cancer-related deaths in men, with castration-resistant disease exhibiting a 5-year survival rate of only 32%. This underscores the urgent need for novel diagnostic biomarkers and therapeutic strategies. Sulforaphane (SFN), a natural isothiocyanate from cruciferous vegetables with proven anti-cancer properties, presents a prom...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ef248bc8-60fc-592c-9bbd-cc28e114d5b2
DOI
10.21203/rs.3.rs-7993444/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A diagnosis model for prostate adenocarcinoma based on hub genes targeted by sulforaphaneDOI 10.21203/rs.3.rs-7993444/v1
Prostate cancer biomarker analysis and drug target prediction based on bioinformatics analysisSemantic proximity
Establishing a Prognostic Model in Prostate Adenocarcinoma through Comprehensive scRNA-Seq and Bulk RNA-Seq Analysis and ValidationSemantic proximity
Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancerSemantic proximity
Bioinformatics and system biology approaches for identifying potential therapeutic targets for prostate cancerSemantic proximity
Unmasking Neuroendocrine Prostate Cancer with a Machine Learning-Driven 7-Gene Stemness Signature that Predicts ProgressionSemantic proximity
Identification of Cancer Hub Gene Signatures Associated with Immune-Suppressive Tumor Microenvironment and Ovatodiolide as a Potential Cancer Immunotherapeutic AgentSemantic proximity
Predicting Prostate Adenocarcinoma Patients’ Survival and Immune Signature: A Novel Risk Model Based on Telomere-Related GenesSemantic proximity
The cornerstone of early diagnosis and immunotherapy of prostate cancer:screening characteristic genesSemantic proximity
The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinomaSemantic proximity
Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate cancerSemantic proximity
Distinct druggable biological processes in early-onset prostate cancerSemantic proximity
Identification of ARHGEF38, NETO2, GOLM1, and SAPCD2 Associated With Prostate Cancer Progression by Bioinformatic Analysis and Experimental ValidationSemantic proximity
Select a neighboring publication to make it the new centre.